… unquestionable significance among glioblastoma patients. In this review, we highlight these
controversies and other recent work related to bevacizumab for glioblastoma. Cancer 2015;…

… and controversies regarding the optimal use of bevacizumab, the … data of bevacizumab in
patients with recurrent GBM, the … of bevacizumab, and ongoing investigations of bevacizumab …

Individuals with glioblastoma are often characterized by … Administration of bevacizumab (BV,
Avastin ® ) promotes tumor … with malignant gliomas, including glioblastoma. Although the …

… in recurrent glioblastoma also showed an effect only … bevacizumab even for recurrent
glioblastoma is controversial. Here, we discuss the clinical impact of bevacizumab for glioblastoma …

… FDA grants accelerated approval of Avastin for brain cancer (glioblastoma) that has
progressed following prior therapy. (2009). www.gene.com/gene/news/press-releases/display.do?…

… the role of bevacizumab, … controversies about bevacizumab in the treatment of GBM still
remain. In this article, we summarized the principal controversies about the use of bevacizumab …

… bevacizumab and its subsequent US FDA approval have given more hope to recurrent GBM
and this concise review discusses bevacizumab … Controversy continues to exist in regards to …

… and current problems associated with bevacizumab in the treatment of glioblastoma and …
This article reviews the efficacy and current problems of bevacizumab therapy against GBM …

… Controversy persists regarding whether bevacizumab should be discontinued upon
progression. Due to the lack of efficacious salvage treatments and the fear of rebound, treatment …

… Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults.
Despite the current … Phase II clinical trials with bevacizumab for recurrent GBM led to its US …